SUN PHARMACEUTICAL INDUSTRIES LTD. Sun Pharmaceutical Industries Ltd. Share Price Bombay S.E.
Equities
SUNPHARMA
INE044A01036
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,466 INR | -0.27% |
|
-3.26% | +16.38% |
| 21/06 | Japanese Stocks End Little Changed After Three-Day Winning Streak on Inflation and Yen Woes | MT |
| 21/06 | Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India | RE |
| Sales 2024 | 485B 5.81B | Sales 2025 * | 532B 6.36B | Capitalization | 3,520B 42.14B |
|---|---|---|---|---|---|
| Net income 2024 | 95.76B 1.15B | Net income 2025 * | 110B 1.32B | EV / Sales 2024 | 7.68 x |
| Net cash position 2024 | 163B 1.95B | Net cash position 2025 * | 183B 2.19B | EV / Sales 2025 * | 6.28 x |
| P/E ratio 2024 |
40.6
x | P/E ratio 2025 * |
32
x | Employees | 41,000 |
| Yield 2024 |
0.83% | Yield 2025 * |
0.96% | Free-Float | 45.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sun Pharmaceutical Industries Ltd.
More recommendations
More press releases
More news
| 1 day | -0.27% | ||
| 1 week | -3.26% | ||
| Current month | +0.43% | ||
| 1 month | -4.79% | ||
| 3 months | -8.80% | ||
| 6 months | +17.91% | ||
| Current year | +16.38% |
1 week
1 461.40
1 530.00
1 month
1 376.751 530.00
Current year
1 258.101 638.70
1 year
986.401 638.70
3 years
661.801 638.70
5 years
315.201 638.70
10 years
315.201 638.70
| Managers | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Founder | 68 | 01/82/01 | |
| Director of Finance/CFO | - | 19/17/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 68 | 01/82/01 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21/21/21 |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15/23/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/24/21 | 1,466 | -0.27% | 418,794 |
| 20/24/20 | 1,470 | -2.24% | 168,755 |
| 19/24/19 | 1,504 | -1.09% | 39,453 |
| 18/24/18 | 1,521 | +0.32% | 20,102 |
| 14/24/14 | 1,516 | +0.39% | 49,020 |
Delayed Quote Bombay S.E., June 21, 2024 at 03:30 pm IST
More quotes
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
02/08/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,467
INR
Average target price
1,619
INR
Spread / Average Target
+10.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.78% | 21.72B | |
| +21.14% | 15.75B | |
| +23.69% | 14.89B | |
| +57.44% | 13.06B | |
| -0.05% | 6.79B | |
| -14.94% | 6.3B | |
| +20.03% | 6.05B | |
| -8.87% | 5.73B | |
| +6.29% | 4.58B |
- Stock Market
- Equities
- SUNPHARMA Stock
- SUNPHARMA Stock
